| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | OPEXA THERAPEUTICS INC | 34,097 | 2,000 | 0.00% | ||
| 2 | PERSEON EQUITY WARRANTS | 1,887,892 | 4,000 | 0.00% | ||
| 3 | RENNOVA HEALTH INC | 30,761 | 23,000 | 0.00% | ||
| 4 | INTELLIPHARMACEUTICS INTL IN | 122 | 25,000 | 0.00% | Put | |
| 5 | CELSION CORPORATION COM PAR | 18,789 | 27,000 | 0.00% | ||
| 6 | GALENA BIOPHARMA INC | 235 | 34,000 | 0.00% | Put | |
| 7 | ANTARES PHARMA INC | 399 | 35,000 | 0.00% | Call | |
| 8 | TENAX THERAPEUTICS INC | 173 | 35,000 | 0.00% | Call | |
| 9 | TONIX PHARMACEUTICALS HLDG C | 148 | 36,000 | 0.00% | Call | |
| 10 | ALLIQUA BIOMEDICAL INC | 483 | 40,000 | 0.00% | Call | |
| 11 | CYTRX CORP | 170 | 46,000 | 0.00% | Call | |
| 12 | BRAINSTORM CELL THERAPEUTICS INC. | 175 | 47,000 | 0.00% | Call | |
| 13 | CELLECTAR BIOSCIENCES INC | 65,362 | 47,000 | 0.00% | ||
| 14 | Eyegate Pharmaceuticaals | 65,393 | 49,000 | 0.00% | ||
| 15 | ANTHERA PHARMACEUTICALS INC | 151 | 55,000 | 0.00% | Call | |
| 16 | AVALANCHE BIOTECHNOLOGIES INC | 106 | 55,000 | 0.00% | Call | |
| 17 | PROGENICS PHARMACEUTICALS IN | 130 | 57,000 | 0.00% | Put | |
| 18 | AKEBIA THERAPEUTICS INC | 100 | 90,000 | 0.00% | Call | |
| 19 | CYMABAY THERAPEUTICS INC | 67,534 | 91,000 | 0.00% | ||
| 20 | BENITEC BIOPHARMA LTD | 99,555 | 100,000 | 0.01% | ||
| 21 | BIODEL INC | 357,500 | 118,000 | 0.01% | ||
| 22 | NORTHWEST BIOTHERAPEUTICS IN | 813 | 119,000 | 0.01% | Put | |
| 23 | KITOV PHARMACEUTICALS HLDGS | 114,720 | 126,000 | 0.01% | ||
| 24 | TRILLIUM THERAPEUTICS INC | 14,137 | 131,000 | 0.01% | ||
| 25 | ARALEZ PHARMACEUTICALS INC | 375 | 133,000 | 0.01% | Call | |
| 26 | NXSTAGE MEDICAL INC | 100 | 150,000 | 0.01% | Put | |
| 27 | NEUROMETRIX INC | 84,263 | 154,000 | 0.01% | ||
| 28 | SYNERGY PHARMACEUTICALS DEL | 285,414 | 157,000 | 0.01% | ||
| 29 | CERES INC | 720,378 | 158,000 | 0.01% | ||
| 30 | ArQule Inc | 100,000 | 160,000 | 0.01% | ||
| 31 | RENNOVA HEALTH INC | 3,225,806 | 161,000 | 0.01% | ||
| 32 | AMARIN CORP PLC | 1,118 | 171,000 | 0.01% | Put | |
| 33 | Aldeyra Therapeutics Inc | 41,096 | 172,000 | 0.01% | ||
| 34 | ARDELYX INC COM | 22,278 | 173,000 | 0.01% | ||
| 35 | MANNKIND CORP | 1,096 | 176,000 | 0.01% | Put | |
| 36 | CLOVIS ONCOLOGY INC | 100 | 192,000 | 0.01% | Put | |
| 37 | TRANSENTERIX INC | 482 | 205,000 | 0.01% | Put | |
| 38 | LPATH INC | 1,106,870 | 206,000 | 0.01% | ||
| 39 | DERMIRA INC | 100 | 207,000 | 0.01% | Put | |
| 40 | CANCER GENETICS | 81,300 | 231,000 | 0.01% | ||
| 41 | HERON THERAPEUTICS INC | 126 | 239,000 | 0.01% | Call | |
| 42 | CELLECTAR BIOSCIENCES IN | 71,313 | 242,000 | 0.01% | ||
| 43 | NANOSPHERE INC | 308,147 | 243,000 | 0.01% | ||
| 44 | JUNO THERAPEUTICS INC | 67 | 255,000 | 0.01% | Call | |
| 45 | CLOVIS ONCOLOGY INC | 13,326 | 256,000 | 0.01% | ||
| 46 | THERAPEUTICSMD INC | 404 | 259,000 | 0.01% | Put | |
| 47 | ARBUTUS BIOPHARMA CORP | 630 | 260,000 | 0.01% | Call | |
| 48 | VERTEX PHARMACEUTICALS INC | 33 | 262,000 | 0.01% | Put | |
| 49 | CHIMERIX INC | 53,620 | 274,000 | 0.01% | ||
| 50 | PROVECTUS | 726,200 | 275,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-101848, filed 2016.05.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
